PFIZER INC Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax
PFIZER INC (PFE) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax of $16.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax · last filed 2026-02-26
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), before tax for the quarter ending 2020-12-31 was -$52.00M, a 966.67% decline year-over-year.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), before tax for the quarter ending 2020-09-27 was $0.00.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), before tax for the quarter ending 2020-06-28 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), before tax for the quarter ending 2019-12-31 was $6.00M, a 33.33% decline year-over-year.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), before tax for fiscal 2025 was $16.00M.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), before tax for fiscal 2024 was -$193.00M, a 872.00% decline from fiscal 2023.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), before tax for fiscal 2023 was $25.00M, a 4.17% increase from fiscal 2022.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), before tax for fiscal 2022 was $24.00M.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | $16.00M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | -$193.00M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $25.00M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $24.00M 10-K · filed 2025-02-27 | |||
| 2021-12-31 | -$116.00M 10-K · filed 2024-02-22 | |||
| 2020-12-31 | -$52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$52.00M derived: sum of 2 quarters · filed 2023-02-23 | -$52.00M derived: sum of 3 quarters · filed 2023-02-23 | -$52.00M 10-K · filed 2023-02-23 |
| 2020-09-27 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |
| 2020-06-28 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||
| 2019-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $6.00M derived: sum of 2 quarters · filed 2022-02-24 | $7.00M derived: sum of 3 quarters · filed 2022-02-24 | $7.00M 10-K · filed 2022-02-24 |
| 2019-09-29 | $0.00 10-Q · filed 2020-11-05 | $1.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.00M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $1.00M 10-Q · filed 2020-08-06 | $1.00M 10-Q · filed 2020-08-06 | ||
| 2018-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $9.00M derived: sum of 2 quarters · filed 2021-02-25 | $9.00M derived: sum of 3 quarters · filed 2021-02-25 | $9.00M 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-07-01 | $0.00 10-Q · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $0.00 derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-04-01 | $0.00 10-Q · filed 2018-05-10 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $2.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $2.00M derived: sum of 3 quarters · filed 2020-02-27 | $2.00M 10-K · filed 2020-02-27 |
| 2017-10-01 | $0.00 10-Q · filed 2018-11-08 | $2.00M derived: sum of 2 quarters · filed 2018-11-08 | $2.00M 10-Q · filed 2018-11-08 | $0.00 derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-07-02 | $2.00M 10-Q · filed 2018-08-09 | $2.00M 10-Q · filed 2018-08-09 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | -$95.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-04-02 | $0.00 10-Q · filed 2018-05-10 | -$2.00M derived: sum of 2 quarters · filed 2019-02-28 | -$97.00M derived: sum of 3 quarters · filed 2019-02-28 | -$184.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$97.00M derived: sum of 2 quarters · filed 2019-02-28 | -$184.00M derived: sum of 3 quarters · filed 2019-02-28 | -$184.00M 10-K · filed 2019-02-28 |
| 2016-10-02 | -$95.00M 10-Q · filed 2017-11-09 | -$182.00M derived: sum of 2 quarters · filed 2017-11-09 | -$182.00M 10-Q · filed 2017-11-09 | -$108.00M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-07-03 | -$87.00M 10-Q · filed 2017-08-10 | -$87.00M 10-Q · filed 2017-08-10 | -$13.00M derived: sum of 3 quarters · filed 2018-02-22 | -$13.00M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-04-03 | $0.00 10-Q · filed 2017-05-11 | $74.00M derived: sum of 2 quarters · filed 2018-02-22 | $74.00M derived: sum of 3 quarters · filed 2018-02-22 | -$433.00M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $74.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $74.00M derived: sum of 2 quarters · filed 2018-02-22 | -$433.00M derived: sum of 3 quarters · filed 2018-02-22 | -$432.00M 10-K · filed 2018-02-22 |
| 2015-09-27 | $0.00 10-Q · filed 2016-11-10 | -$507.00M derived: sum of 2 quarters · filed 2016-11-10 | -$506.00M 10-Q · filed 2016-11-10 | -$1.25B derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-28 | -$507.00M 10-Q · filed 2016-08-11 | -$506.00M 10-Q · filed 2016-08-11 | -$1.25B derived: sum of 3 quarters · filed 2017-02-23 | -$1.25B derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-29 | $1.00M 10-Q · filed 2016-05-12 | -$745.00M derived: sum of 2 quarters · filed 2017-02-23 | -$745.00M derived: sum of 3 quarters · filed 2017-02-23 | -$745.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | -$746.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$746.00M derived: sum of 2 quarters · filed 2017-02-23 | -$746.00M derived: sum of 3 quarters · filed 2017-02-23 | -$746.00M 10-K · filed 2017-02-23 |
| 2014-09-28 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | -$148.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-29 | $0.00 10-Q · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | -$148.00M derived: sum of 3 quarters · filed 2016-02-29 | -$148.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-30 | $0.00 10-Q · filed 2015-05-07 | -$148.00M derived: sum of 2 quarters · filed 2016-02-29 | -$148.00M derived: sum of 3 quarters · filed 2016-02-29 | -$148.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$148.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$148.00M derived: sum of 2 quarters · filed 2016-02-29 | -$148.00M derived: sum of 3 quarters · filed 2016-02-29 | -$151.00M 10-K · filed 2016-02-29 |
| 2013-09-29 | $0.00 10-Q · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | -$3.00M 10-Q · filed 2014-11-06 | -$5.00M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 | -$3.00M 10-Q · filed 2014-08-07 | -$5.00M derived: sum of 3 quarters · filed 2015-02-27 | -$2.00M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | -$3.00M 10-Q · filed 2014-05-08 | -$5.00M derived: sum of 2 quarters · filed 2015-02-27 | -$2.00M derived: sum of 3 quarters · filed 2015-02-27 | -$28.00M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $1.00M derived: sum of 2 quarters · filed 2015-02-27 | -$25.00M derived: sum of 3 quarters · filed 2015-02-27 | -$25.00M 10-K · filed 2015-02-27 |
| 2012-09-30 | $3.00M 10-Q · filed 2013-11-08 | -$23.00M derived: sum of 2 quarters · filed 2013-11-08 | -$23.00M 10-Q · filed 2013-11-08 | -$128.00M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-07-01 | -$26.00M 10-Q · filed 2013-08-09 | -$26.00M 10-Q · filed 2013-08-09 | -$131.00M derived: sum of 3 quarters · filed 2014-02-28 | -$131.00M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-04-01 | $0.00 10-Q · filed 2013-05-10 | -$105.00M derived: sum of 2 quarters · filed 2014-02-28 | -$105.00M derived: sum of 3 quarters · filed 2014-02-28 | -$107.00M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | -$105.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$105.00M derived: sum of 2 quarters · filed 2014-02-28 | -$107.00M derived: sum of 3 quarters · filed 2014-02-28 | -$106.00M 10-K · filed 2014-02-28 |
| 2011-10-02 | $0.00 10-Q · filed 2012-11-09 | -$2.00M derived: sum of 2 quarters · filed 2012-11-09 | -$1.00M 10-Q · filed 2012-11-09 | |
| 2011-07-03 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$1.00M 10-Q · filed 2012-08-09 | ||
| 2011-04-03 | $1.00M 10-Q · filed 2012-05-10 | |||
| 2010-12-31 | -$550.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |